JohnsonP.C., BertramT.A., TawilB., HellmanK.B.Hurdles in tissue engineering/regenerative medicine product commercialization: a survey of North American academia and industry. Tissue Eng Part A, 17:5. 2011.
2.
HellmanK.B., JohnsonP.C., BertramT.A., TawilB.Challenges in tissue engineering and regenerative medicine product commercialization: building an industry. Tissue Eng Part A, 17:1. 2011.
3.
BertramT.A., TentoffE., JohnsonP.C., TawilB., Van DykeM., HellmanK.B.Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry. Tissue Eng Part A, 18:2187. 2012.
4.
LysaghtM.J., JaklenecA., DeweerdE.Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Eng Part A, 14:305. 2008.
5.
LysaghtM.J., HazlehurstA.L.Tissue engineering: the end of the beginning. Tissue Eng, 10:309. 2004.
6.
LysaghtM.J., HazlehurstA.L.Private sector development of stem cell technology and therapeutic cloning. Tissue Eng, 9:555. 2003.
7.
LysaghtM.J., ReyesJ.The growth of tissue engineering. Tissue Eng, 7:485. 2001.
8.
LysaghtM.J., NguyN.A., SullivanK.An economic survey of the emerging tissue engineering industry. Tissue Eng, 4:23. 1998.
9.
LysaghtM.J.Product development in tissue engineering. Tissue Eng, 1:221. 1995.
